You are here

Fresenius ups profit forecast on strong growth in generic drugs

Thursday, May 4, 2017 - 05:50

Frankfurt

GERMAN healthcare group Fresenius on Wednesday toned up its earnings guidance for the year as demand for recently launched generic infusion drugs continued to grow at higher-than-expected rates.

For 2017, it now expects adjusted net income to grow by 19 to 21 per cent,

sentifi.com

Market voices on:

Nespresso
Pair your daily business read with the perfect cup of espresso.

Subscribe to The Business Times today to receive your very own Nespresso Inissia coffee machine worth $188.

Find out more at btsub.sg/btdeal

Powered by GET.comGetCom